S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

CVE:IGPImperial Ginseng Products Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range
C$0.27
MA: C$0.31
C$0.33
52-Week Range N/A
Volume2,051 shs
Average Volume2,266 shs
Market CapitalizationC$2.42 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Imperial Ginseng Products Ltd. cultivates and processes ginseng in the province of Ontario. It is also involved in the sale of dried ginseng to wholesalers through distributors in Asia and North America. The company was founded in 1989 and is headquartered in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars


Industry, Sector and Symbol

Industry Farm Products
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+1-604-6898863

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$5.38 million
Book ValueC$2.95 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$2.42 million
Next Earnings Date10/9/2020 (Estimated)
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive IGP News and Ratings via Email

Sign-up to receive the latest news and ratings for IGP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Imperial Ginseng Products (CVE:IGP) Frequently Asked Questions

When is Imperial Ginseng Products' next earnings date?

Imperial Ginseng Products is scheduled to release its next quarterly earnings announcement on Friday, October 9th 2020.
View our earnings forecast for Imperial Ginseng Products
.

How were Imperial Ginseng Products' earnings last quarter?

Imperial Ginseng Products Ltd. (CVE:IGP) issued its quarterly earnings data on Friday, May, 15th. The company reported ($0.11) earnings per share (EPS) for the quarter. The company earned $3.52 million during the quarter.
View Imperial Ginseng Products' earnings history
.

Has Imperial Ginseng Products been receiving favorable news coverage?

News coverage about IGP stock has been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Imperial Ginseng Products earned a news sentiment score of -1.2 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term.
View the latest news about Imperial Ginseng Products
.

Who are some of Imperial Ginseng Products' key competitors?

What other stocks do shareholders of Imperial Ginseng Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Imperial Ginseng Products investors own include Abercrombie & Fitch (ANF), Canadian Natural Resources (CNQ), Canadian Natural Resources (CNQ), Jamieson Wellness (JWEL), Maxar Technologies (MAXR), Bristol-Myers Squibb (BMY), Corning (GLW), Globalstar (GSAT), SRC Energy (SRCI) and Total System Services (TSS).

Who are Imperial Ginseng Products' key executives?

Imperial Ginseng Products' management team includes the following people:
  • Mr. Stephen P. McCoach CA, CPA, Chairman, CEO & Sec. (Age 60)
  • Ms. Amelia Yeo, Chief Financial Officer (Age 54)
  • Mr. Maurice A. Levesque, Exec. VP & Exec. Director (Age 60)
  • Mr. Michael Peever, Pres of Canadian Imperial Ginseng Ontario Ltd

What is Imperial Ginseng Products' stock symbol?

Imperial Ginseng Products trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IGP."

How do I buy shares of Imperial Ginseng Products?

Shares of IGP and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

How big of a company is Imperial Ginseng Products?

Imperial Ginseng Products has a market capitalization of C$0.00 and generates C$5.38 million in revenue each year.

What is Imperial Ginseng Products' official website?

The official website for Imperial Ginseng Products is www.imperialginseng.com.

How can I contact Imperial Ginseng Products?

Imperial Ginseng Products' mailing address is Suite 3030 650 West Georgia Street, VANCOUVER, BC V6B 4N7, Canada. The company can be reached via phone at +1-604-6898863.

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.